SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-003009
Filing Date
2022-02-10
Accepted
2022-02-10 16:16:06
Documents
64
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vtgn20211231_10q.htm   iXBRL 10-Q 2145662
2 EXHIBIT 31.1 ex_329937.htm EX-31.1 8185
3 EXHIBIT 31.2 ex_329938.htm EX-31.2 8378
4 EXHIBIT 32 ex_329939.htm EX-32 4710
  Complete submission text file 0001437749-22-003009.txt   8035766

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20211231.xsd EX-101.SCH 62853
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtgn-20211231_cal.xml EX-101.CAL 39631
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20211231_def.xml EX-101.DEF 469362
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20211231_lab.xml EX-101.LAB 356348
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20211231_pre.xml EX-101.PRE 489211
58 EXTRACTED XBRL INSTANCE DOCUMENT vtgn20211231_10q_htm.xml XML 1240872
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37761 | Film No.: 22614122
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences